Matthew J Zirwas Katie Wulff Kenneth Beckman
10.1016/j.jdcr.2018.10.016
JAAD Case Rep
2018 Dec 4;5(1):34-36.
diosd, dupilumab-induced ocular surface disease fda, us food and drug administration atopic dermatitis conjunctivitis dupilumab
CC BY-NC-ND
https://pubmed.ncbi.nlm.nih.gov/30555883/
Case Reports
PMC6280680
30555883
Lifitegrast add-on treatment for dupilumab-induced ocular surface disease (DIOSD): A novel case report
2018